We are thrilled to announce that global medtech company BD is joining our Corporate Partnership Programme. A leading stakeholder in the life sciences field that spans medical discovery, diagnostics and care delivery, BD becomes Biopôle’s ninth corporate partner, joining the likes of Roche, Novartis and Terumo. With 75,000 employees and a presence in virtually every country around the globe, BD will be a huge asset to the community.

BD is advancing the world of health^TM – its stated aim is to leverage its global network, which features some of the brightest minds in medtech, to develop cutting-edge technology, services and solutions that can help healthcare professionals and organisations achieve better outcomes and patient experiences. The company’s current focus areas include facilitating smart connected care, creating new care settings and improving chronic disease outcomes by incorporating AI, informatics, robotics and home-based treatments into healthcare processes. Thus, BD hopes to address the sector’s current issues around cost, safety, efficiency and access.

Roland Goette, President of BD EMEA, commented, “Our partnership with Biopôle will fuel our tech scouting initiatives and strengthen relationships in the local innovation community. Given Biopôle’s robust track record of accelerating innovation and facilitating successful collaborations, we look forward to gaining access to Biopôle’s ecosystem while concurrently raising awareness about BD’s commitment to leveraging cutting-edge science and technology.”

Similarly, Nasri Nahas, CEO of Biopôle SA, commented: ‘We are very excited to add an established medtech stakeholder – in the form of BD – to our portfolio of corporate partners. Our members will undoubtedly benefit from physical proximity to this key industry player, which has been driving innovation in the field over the past few years. Welcome, BD!’